Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ARGX
Stock Latest News
The Fly
Argenx upgraded to Buy from Hold at Deutsche Bank
7d ago
ARGX
Premium
The Fly
Argenx assumed with an Overweight at Morgan Stanley
12d ago
ARGX
Premium
Ratings
Argenx’s Strong Growth Prospects and Strategic Positioning Drive Buy Rating
12d ago
ARGX
Premium
Ratings
Argenx Se: Overcoming Volatility with Promising Pipeline and Strong Immunology Position
13d ago
ARGX
Premium
The Fly
Concerns on Vyvgart Hytrulo safety signal look ‘overblown,’ says Citi
14d ago
ARGX
Premium
Ratings
Argenx Se’s Advancements in Neuromuscular Treatment Pipeline Drive Buy Rating
14d ago
ARGX
Premium
The Fly
Argenx selloff overblown, says Wells Fargo
15d ago
ARGX
Premium
Ratings
Argenx Se: Buy Rating Amidst Volatility and Proactive Risk Management
15d ago
ARGX
Premium
The Fly
Argenx weakness presents ‘attractive opportunity,’ says BofA
15d ago
ARGX
Premium
The Fly
FDA flags possible safety signals in new report, says RBC Capital
15d ago
ALKS
ARGX
Premium
Company Announcements
argenx Advances ARGX-119 to Registrational Study for Congenital Myasthenic Syndromes
15d ago
6K
ARGX
Premium
The Fly
Argenx weakness attributed to Vyvgart Hytrulo inclusion on FDA FAERS update
15d ago
ARGX
Premium
The Fly
Argenx announces plan to advance clinical development of ARGX-119
15d ago
ARGX
Premium
Company Announcements
Argenx’s Efgartigimod Study: A Promising Step for ITP Treatment
19d ago
ARGX
Premium
Ratings
Promising Growth Prospects for Argenx Se’s Vyvgart in CIDP and gMG Treatment Drive Buy Rating
21d ago
ARGX
Premium
Company Announcements
Argenx Gains European Approval for Novel CIDP Treatment
25d ago
6K
ARGX
Premium
The Fly
Argenx price target lowered to EUR 650 from EUR 715 at Morgan Stanley
25d ago
ARGX
Premium
The Fly
Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
25d ago
ARGX
HALO
Premium
The Fly
Argenx announces European Commission approval of VYVGART subcutaneous injection
25d ago
ARGX
Premium
Ratings
Promising Clinical Trial Results and Strategic Pipeline Development Position Argenx Se as a Strong Investment Prospect
1M ago
ARGX
Premium
Company Announcements
Argenx SE Reports Promising Phase 2 Results for Efgartigimod in Autoimmune Diseases
1M ago
6K
ARGX
Premium
The Fly
Argenx presents new Efgartigimod data at EULAR 2025
1M ago
ARGX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
